Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravinder Abrol

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Nature Communications|January 30, 2015
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibilityJennifer Wessel, Audrey Y Chu, Sara M Willems, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2017
Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologicsJessica D Sims, Jan Michael Taguiam, Felix Alonso-Valenteen, et al.
Nature Communications|January 30, 2015
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibilityJennifer Wessel, Audrey Y Chu, Sara M Willems, et al.
Pageof 7